Influence of various drugs on the voluntary intake of nicotine by rats

Neuropsychobiology

Volumn 41, Issue 4, 2000, Pages 205-209

  Kameda, G ^a   Dadmarz, M ^a   Vogel, Wolfgang H ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Clozapine; Haloperidol; L dopa; Mecamylamine; Nicotine; Oral nicotine self administration; Pergolide; Rats; Tacrine

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; CLOZAPINE; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; HALOPERIDOL; LEVODOPA; MECAMYLAMINE; NICOTINE; PERGOLIDE; RECEPTOR; TACRINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN; CONTROLLED STUDY; DRINKING; DRUG SELF ADMINISTRATION; FLUID INTAKE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0034097529     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026661     Document Type: Article

References (36)

1. Forth W, Henschler D, Rummel W, Tabak IN: Allgemeine und spezielle Pharmakologie und Toxikologie. Mannheim, Wissenschaftsverlag, 1990, p 804.
2. Leshner A: Addiction research can provide scientific solutions to the problem of cigarette smoking. NIDA Res Monogr 1989;13:3-4.
3. Muscat JE, Stellman SD, Zhang ZF, Neugut Al. Wynder EL: Cigarette smoking and large cell carcinoma of the lung. Cancer Epidemiol Biomarkers Prev 1997;6:477-480.
4. Corrigal WA, Coen KM, Adamson KL: Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res 1989;653:278-284.
5. Valentine JD, Hokanson JS, Malta SG, Sharp BM: Self administration in rats allowed unlimited access to nicotine. Psychopharmacology 1997;133:300-304.
6. Pontieri FE, Tanda G, Di Chiara G: Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the shell as compared in the core of the rat nucleus accumbens. Proc Natl Acad Sci USA 1995;92:12304-12308.
7. Piciotto MR, Zoli M, Rimondini R, Lena C, Maruhio LM, Pich EM, Fuxe K, Changeux JP: Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature 1998;391:173-177.
8. Pidoplichko VI, DeBiasi M, Williams JT, Dani JA: Nicotine activates and desensitizes midbrain dopamine neurons. Nature 1997;390: 401-404.
9. Fung YK, Schmid MJ, Anderson TM, Lau YS: Effects of nicotine withdrawal on central dopaminergic systems. Pharmacol Biochem Behav 1996;53:635-640.
10. Yeomans J, Baptista M: Both nicotinic and muscarinic receptors in the ventral tegmental area contribute to brain-stimulation reward. Pharmacol Biochem Behav 1997;57:915-921.
11. Grenhoff J, Svensoon TH: Nicotine effects on the firing pattern of midbrain dopamine neurons. Acta Physiol Scand 1992;28:351-358.
12. Dichiara G, Imperato A: Drugs abused by humans preferentially increase synaptic dopamine concentration in the mesolimbic dopamine system of freely moving rats. Proc Natl Acad Sci USA 1988;85:5274-5278.
13. Balfour DJ, Benwell ME, Birrel CE, Kelley RJ, Al-Aloul M: Sensitization of the mesoaccumbens dopamine responses to nicotine. Pharmac Biochem Behav 1998;59:1021-1030.
14. McGehee DS, Role LW: Physiological diversity of nicotine acetylcholine receptors expressed by vertebrate neurons. Annu Rev Physiol 1995; 57:521-546.
15. Changueux JP, Galzi JL, Devillers-Thiery A, Bertrand D: The functional architecture of the acetylcholine nicotinic receptor explored by affinity labeling and site-directed mutagenesis. Q Rev Biophys 1992;25:395-432.
16. Pidoplichko VI, DeBiasi M, Williams JT, Dani JA: Nicotine activates and desensitizes midbrain dopamine neurons. Nature 1997;390: 401-404.
17. Houston-Lyons D, Kornetsky C: Effects of nicotine on the threshold for rewarding brain stimulation in rats. Pharmacol Biochem Behav 1992;41:755-759.
18. Stolerman IP, Pratt JA, Garcha HS, Giardini V, Kumar R: Nicotine cue in rats analyzed with drugs acting on cholinergic and 5-hydroxytryptamine mechanisms. Neuropharmacology 1983;22:1029-1037.
19. Wilde CH, Vogel WH: Influence of 5-HT1 receptor agonist ipsapirone on voluntary alcohol intake in rats. Alcohol 1994;5:411-415.
20. Mosner A, Kuhlman G, Roehm C, Vogel WH: Serotonergic receptors modify the voluntary intake of alcohol and morphine but not of cocaine and nicotine by rats. Pharmacolgy 1997; 88:420-425.
21. Corrigal WA, Coen KM: Selective dopamine antagonists reduce nicotine self-administration. Psychopharmacology 1991;104:171-176.
22. Glick SD, Visker KE, Maisonneuve IM: An oral self-administration model of nicotine preference in rats: Effects of mecamylamine. Psychopharmacology 1996;128:426-431.
23. Shoaib M, Schindler CW, Goldberg SR: Nicotine self-administration in rats: Strain and nicotine pre-exposure effects on acquisition. Psychopharmacology 1997;129:35-43.
24. Schmitt U, Dahmen N, Fischer V, Weigmann H, Rao ML, Reusws S, Hiemke C: Chronic oral haloperidol and clozapine in rats: A behavioral evaluation. Neuropsychobiology 1999;39:86-91.
25. Ivanova S, Greenshaw AJ: Nicotine-induced decreases in VTA electrical self-stimulation thresholds: Blockade by haloperidol and mecamylamine hut not scopolamine or ondansetron. Psychopharmacology 1997;134:187-192.
26. Collins AC, Luo Y, Selvag S, Marks MJ: Sensitivity to nicotine and brain receptors are altered by chronic nicotine and mecamylamine infusions. J Pharmacol Exp Ther 1994;271: 125-133.
27. Clarke PB, Davina SF, Jakubovic A, Fibinger HC: Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats. J Pharmacol Exp Ther 1988;246:701-708.
28. Nutt JG, Fellmann JH: The pharmacokinetics of L-DOPA. Clin Neuropharmacol 1988;7:35-48.
29. Fuller RW, Clemens JR: Pergolide: A dopaminergic agonist at both D1 and D2 receptors. Life Sci 1991;49:925-929.
30. Creese I, Burl DR, Snyder SH: Dopamine receptor binding: Differentiation of agonist and antagonist states with dopamine and haloperidol. Life Sci 1975;17:993-996.
31. Baldessarini RJ, Frankenburg FR: Clozapine: A novel antipsychotic agent. N Engl J Med 1991;324:746-751.
32. Clarke PB, Reuben M, el-Bizri H: Blockade of nicotinic responses by physostigmine, tacrine and other cholinesterase inhibitors in rat striatum. BrJ Pharmacol 1994;111:695-702.
33. Brioni JD, Kim DJ, O'Neill AB, Williams JE, Decker MW: Clozapine attenuates the discriminative stimulus properties of (-)-nicotine. Brain Res 1994;18:1-9.
34. George TP, Sernyak MJ, Ziedonis DM, Woods SW: Effects of clozapine on smoking in chronic schizophrenic outpatients. J Clin Psychiatry 1995;56:344-346.
35. McEvoy JP, Freudenreich O, McGee M, VanderZwaag C, Levin ED, Rose JE: Clozapine decreases smoking in patients with chronic schizophrenia. Biol Psychiatry 1995;37:550-552.
36. Ufer M, Dadmarz M, Vogel WH: Voluntary consumption of amphetamine, cocaine, ethanol and morphine by rats as influenced by a preceding period of forced drug intake and clozapine. Pharmacology 1999;58:285-291.